Published: 2022 June 06
Female Sterilization Procedures Market
180 pages
Report Summary
Table of Contents
List of Tables & Figures

Female Sterilization Procedures Market is segmented by Procedure Type (Surgical and Non-Surgical), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029


Female sterilization procedure market is expected to grow at a CAGR of 5.60% during the forecast period 2022-2029.

Female Sterilization Procedures Market



Market CAGR


Segments Covered

By Type, By Application, By End User, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

To Get a Free Sample Click here

National Health Service (NHS) of the U.K states that female sterilization is an operation to prevent pregnancy permanently. The fallopian tubes are either clogged or latched to prevent the eggs from reaching the sperm and fertilizing.

Market Dynamics

The rising awareness about female health issues, the growing population, and the increasing research and development are accelerating the female sterilization procedures market growth globally.

The increasing research and development in female contraception procedures and the growing population propel the market growth.

The increasing research and development in female contraception procedures drive global market growth. For instance, the microneedle contraceptive skin patch development is a device that slow-releases hormones; that is a simple, long-acting form of contraception that does not need a health professional to be administered. Followed by pressing the patch to the skin for one minute, the microneedles will rapidly detach from the patch within the skin and slowly release levonorgestrel for about 1 month. Also, the research on antibodies as a non-hormonal contraceptive, the Scientists at the University of North Carolina at Chapel Hill are developing potent monoclonal antibodies that bind sperm to offer an inexpensive and non-hormonal form of female contraception, offering women another non-hormonal option to prevent pregnancies. Furthermore, the increasing population globally is increasing the need for permanent contraception. For instance, according to the US census, there is one birth every 8 seconds with one death every 12 seconds, and the current global population is ~8 billion, and at this rate will reach 9.8 billion by 2030, which will create a scarcity of food, land, medical services, and many other needs.

The lack of safety and the high cost slow the global female sterilization procedures market growth.

However, some reasons, like the side effects, lack safety, and the high cost of female sterilization procedures, are likely to slow down the growth of this market in the forecast period.

COVID-19 Impact Analysis

COVID-19 disturbed the global supply and demand chain, which has negatively impacted the global market growth as there were restrictions imposed to restrict the spread of COVID-19 infection. Furthermore, because of the socializing restrictions imposed, the planned sterilization procedures were either postponed or canceled, thereby negatively impacting the global female sterilization procedure market.

Segment Analysis

The surgical procedure is anticipated to grow at the fastest CAGR during the forecast period (2022-2029).

The surgical procedure is expected to dominate the global market throughout the forecast period (2022-2029), owing to the advantages offered by the surgical method, such as being a very effective and permanent method of contraception, does not affect sex drive, doesn’t interfere with the spontaneity of sexual intercourse. There is no effect on your normal hormonal rhythms or periods. Furthermore, minimally invasive surgery makes it safe, with minimal side effects, risks, and high effectiveness (99%) method, ensuring the dominance of female surgical sterilization over the global market during the forecast period.

Geographical Analysis

The North American region commands the global female sterilization procedures market.

The factors include the growing number of unintended pregnancies, the presence of key market players, and better cost reimbursement policies in North America contribute to the dominance of this region over the global market. For instance, the unintended pregnancy rate is significantly higher in the United States than in many other developed countries. Unplanned pregnancy rates are highest among low-income women, women aged 18–24, cohabiting women, and women of color. Rates appear to be lowest among higher-income women, white women, college graduates, and married women. Furthermore, according to CDC, in 2020, over 3,613,647 births occurred, making the birth rate 11.0 per 1,000 population and the fertility rate 56.0 births per 1,000 women aged 15-44; out of these births, over 40.5% of mothers were unmarried.

Moreover, using the Medicaid data, researchers identified 5,906 women who had undergone hysteroscopic and 23,965 who had undergone laparoscopic sterilization, having an average age of 33. In addition, key market players such as Hologic, Inc., CONMED Corporation, Ethicon, Inc., Cooper Surgical, Boston Scientific Corporation, Cardinal Health, and American Medical Systems hold a large share of the global market. They are U.S.-based, ensuring North America`s dominance globally.

Competitive Landscape

Some key players are Bayer AG, Hologic, Inc., CONMED Corporation, Ethicon, Inc., Cooper Surgical, Boston Scientific Corporation, Olympus Corporation, Pregna International, Cardinal Health, and American Medical Systems. These key players hold the major share of the market through innovations, product launches, collaborations, acquisitions, and alliances. For instance, in November 30, 2021, Hologic acquired Bolder Surgical. Also, in August 18, 2022, Mirena from Bayer secured approval in the US for an extended duration of use in contraception.

Hologic, Inc.


Hologic, Inc. is among the leading medical technology companies involved in research and manufacturing products for women’s health, including medical devices for diagnostics, surgery, and medical imaging. Hologic, Inc. is headquartered in Massachusetts, U.S. and was founded in 1985; it also has a global presence, With locations in over 15 countries and more than 5,500 employees globally.

Product Portfolio:

 The product portfolio of Hologic, Inc. for female sterilization procedures has JustRight Surgical Stapler, Omni hysteroscope, CoolSeal Vessel Sealing Portfolio, Etc.

The global female sterilization procedures market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Trending Topics

In vitro fertilization (IVF) Market

Menopause Treatment Market

GnRH Agonists & Antagonists Drugs for Endometriosis Market

Buy this report
Single User
Multiple User
Enterprise User
Proceed to Buy